Ucci-Bn-16-01- A Phase 0/1 Exploratory Pharmacokinetic And Pharmacodynamics Study Of Letrozole In Combination With Standard Therapy In Recurrent Gliomas.
Posted Date: May 15, 2019
- Investigator: Trisha Wise-Draper
- Specialties: Cancer, Oncology
- Type of Study: Drug
The goal of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in high grade gliomas.
To Be Eligible: Age 18 Or Older, Must Have Recurrent High Grade Glioma, Nonpregnant/Breastfeeding, No Other Uncontrolled Illness
Brain Cancer, Glioma, Phase I, Phase 0
For More Information:
Uc Cancer Institute